Nightingale Health Oyj (HEALTH) Fair Value & Analysis
Healthcare · FI · Market cap €51.8M
Fair value as of: Jun 25, 2026
Analysis
Nightingale Health Oyj (HEALTH) currently trades at €0.8200, while our model-based Fair Value estimate is €1.14 — implying the stock looks roughly 39.0% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
About the company
Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely. It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare providers. Nightingale Health Oyj was incorporated in 2002 and is headquartered in Helsinki, Finland.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Nightingale Health Oyj (HEALTH) undervalued?
What is the fair value of HEALTH?
What is the quality score of HEALTH?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.